Neuralink Corp., Elon Musk’s pioneering venture in the field of neurotechnology, has closed a landmark Series E funding round totaling 650 million USD. The round, disclosed on Monday, attracted significant attention from at least 11 major investors, including ARK Investment Management, Founders Fund, and Sequoia Capital. This latest injection of capital marks one of the largest fundraising events in the nascent brain-computer interface (BCI) sector, underscoring robust institutional confidence.

Neuralink, the pioneering company in brain implant technology founded by Elon Musk, is embarking on a significant expansion phase. Recent reports by Bloomberg News reveal that Neuralink is preparing to raise approximately $500 million in a new funding round, envisaged with a pre-money valuation of $8.5 billion. This substantial boost in capital follows an earlier valuation of $5 billion in 2023 based on private share transactions, showcasing an accelerating trajectory in technological and financial progress.